Mycobacterium tuberculosis Lineage Distribution Using Whole-Genome Sequencing and Bedaquiline, Clofazimine, and Linezolid Phenotypic Profiles among Rifampicin-Resistant Isolates from West Java, Indonesia

Mycobacterium tuberculosis Lineage Distribution Using Whole-Genome Sequencing and Bedaquiline, Clofazimine, and Linezolid Phenotypic Profiles among Rifampicin-Resistant Isolates from West Java, Indonesia

Tuberculosis (TB) is caused by Mycobacterium tuberculosis infection. Indonesia is ranked second in the world for TB cases. New anti-TB drugs from groups A and B, such as bedaquiline, clofazimine, and linezolid, have been shown to be effective in curing drug resistance in TB patients, and Indonesia i...

Full description

Bibliographic Details
Main Authors:	Andriansjah Rukmana, Cynthia Gozali, Linda Erlina
Format:	Article
Language:	English
Published:	Hindawi Limited 2024-01-01
Series:	International Journal of Microbiology
Online Access:	http://dx.doi.org/10.1155/2024/2037961

Similar Items

Bedaquiline, Delamanid, Linezolid, Clofazimine, and Capreomycin MIC Distributions for Drug Resistance Mycobacterium tuberculosis in Shanghai, China
by: Guo Y, et al.
Published: (2023-12-01)

Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in Mycobacterium tuberculosis
by: N. Ismail, et al.
Published: (2018-10-01)

First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda
by: Jupiter Marina Kabahita, et al.
Published: (2022-05-01)

Bedaquiline and clofazimine: successes and challenges
by: Norbert Ndjeka, et al.
Published: (2020-08-01)

Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
by: Sonnenkalb, L, et al.
Published: (2023)

Molecular mechanisms of resistance and treatment efficacy of clofazimine and bedaquiline against Mycobacterium tuberculosis
by: Md Mahmudul Islam, et al.
Published: (2024-01-01)

Spontaneous mutational patterns and novel mutations for bedaquiline and clofazimine resistance in Mycobacterium tuberculosis
by: Jin Shi, et al.
Published: (2023-10-01)

Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis
by: Camus Nimmo, et al.
Published: (2024-02-01)

Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678
by: J. Snobre, et al.
Published: (2023-06-01)

Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients
by: Yuanyuan Shang, et al.
Published: (2023-06-01)

Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis
by: Yuhong Liu, et al.
Published: (2021-01-01)

Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro
by: Ronald Anderson, et al.
Published: (2018-11-01)

The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data
by: Shanshan Li, et al.
Published: (2024-01-01)

Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant Mycobacterium Tuberculosis Isolates in Zhejiang, China
by: Tong E, et al.
Published: (2023-10-01)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
by: Jian Du, et al.
Published: (2021-05-01)

Improved outcomes following addition of bedaquiline and clofazimine to a treatment regimen for multidrug-resistant tuberculosis
by: Ge Yao, et al.
Published: (2023-01-01)

A child with acute myeloid leukemia complicated by calcaneal osteomyelitis due to Mycobacterium abscessus infection after induction chemotherapy successfully salvaged with bedaquiline and clofazimine
by: Wilson Yau-Ki Chan, et al.
Published: (2021-02-01)

Evaluation of genetic mutations associated with phenotypic resistance to fluoroquinolones, bedaquiline, and linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis
by: Qi An, et al.
Published: (2023-09-01)

Discovery of a highly potent novel rifampicin analog by preparing a hybrid of the precursors of the antibiotic drugs rifampicin and clofazimine
by: Pasupathy Saravanan, et al.
Published: (2021-01-01)

Role of Clofazimine in Treatment of Mycobacterium avium Complex
by: Mohammad Javad Nasiri, et al.
Published: (2021-04-01)

Effects of Bedaquiline Combined with Fluoroquinolone and/or Clofazimine on QT Interval in Patients with Multidrug-Resistant Tuberculosis: a Retrospective Study
by: Rong Li, et al.
Published: (2023-08-01)

Effects of a rifampicin pre-treatment on linezolid pharmacokinetics.
by: Fumiyasu Okazaki, et al.
Published: (2019-01-01)

Rv1453 is associated with clofazimine resistance in Mycobacterium tuberculosis
by: Lei Zhang, et al.
Published: (2023-10-01)

Acquired resistance of Mycobacterium tuberculosis to bedaquiline.
by: Koen Andries, et al.
Published: (2014-01-01)

Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies
by: Satsuki Hashimoto, et al.
Published: (2018-11-01)

Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in Mycobacterium tuberculosis
by: Qinglong Guo, et al.
Published: (2022-05-01)

Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates
by: Kamal Singh, et al.
Published: (2022-10-01)

Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen
by: Olatunde Olayanju, et al.
Published: (2019-08-01)

Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis
by: Camus Nimmo, PhD, et al.
Published: (2020-08-01)

Whole genome sequencing of Bulgarian rifampicin resistant Mycobacterium tuberculosis strains
by: Stanislava Yordanova, et al.
Published: (2022-08-01)

Clofazimine susceptibility testing of Mycobacterium avium complex and Mycobacterium abscessus: a meta-analysis study
by: Bahareh Hajikhani, et al.
Published: (2021-09-01)

Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.
by: Tara C Bouton, et al.
Published: (2019-01-01)

Evaluation of the impact of rifampicin on the plasma concentration of linezolid in tuberculosis co-infected patients
by: Pan Yan, et al.
Published: (2023-11-01)

Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China
by: Wencong He, et al.
Published: (2021-09-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.
by: Paul J Converse, et al.
Published: (2015-01-01)

Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages.
by: Yang Degang, et al.
Published: (2012-01-01)

Clofazimine: History and Perspectives
by: G. N. Mozhokina, et al.
Published: (2021-06-01)

Clofazimine for the treatment of tuberculosis
by: Jacob A. M. Stadler, et al.
Published: (2023-02-01)

Molecular Detection of Dapsone and Rifampicin Resistance on Mycobacterium leprae from Leprosy Patients in East Java
by: DINAR ADRIATY, et al.
Published: (2010-03-01)